Steel City Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.61 M
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth 12.41%
- Profit Growth 2.42%
- Ebitda -1.84%
- Net Worth -5.62%
- Total Assets 2.05%
About Steel City Pharmaceuticals
Steel City Pharmaceuticals Pvt Ltd (SCPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 December 1993 and has a history of 31 years and one month. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.61 M.
The company currently has active open charges totaling ₹0.50 M.
Veeru Manthini, Satyanarayana Chaparala, Rama Vemulapalli, and Four other members serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239AP1993PTC016799
-
Company No.
016799
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Dec 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Steel City Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Veeru Manthini | Managing Director | 01-Oct-2002 | Current |
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satyanarayana Chaparala | Director | 12-Aug-2016 | Current |
Rama Vemulapalli | Director | 30-Sep-2006 | Current |
Thirupathi Bommi | Director | 28-Mar-2012 | Current |
Narasimharaju Datlavenkata | Director | 28-Mar-2012 | Current |
Surya Kakarlapudi | Director | 12-Aug-2016 | Current |
Papa Vegi | Director | 30-Sep-2008 | Current |
Financial Performance of Steel City Pharmaceuticals.
Steel City Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 12.41% increase. The company also saw a slight improvement in profitability, with a 2.42% increase in profit. The company's net worth dipped by a decrease of 5.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Steel City Pharmaceuticals?
In 2019, Steel City Pharmaceuticals had a promoter holding of 11.99% and a public holding of 88.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.05 Cr
₹0
Charges Breakdown by Lending Institutions
- The Lakshmi Vilas Bank Limited : 0.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
10 May 1995 | The Lakshmi Vilas Bank Limited | ₹0.50 M | Open |
How Many Employees Work at Steel City Pharmaceuticals?
Unlock and access historical data on people associated with Steel City Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Steel City Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steel City Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.